Loss of SRC-1 expression dramatically increased tumor latency in this model, which correlated with decreased proliferation index and upregulation of cell cycle inhibitors such as transforming growth factor β2 (5.2 fold), Cdkn1a (8.8 fold), and Cdkn2b (8.5 fold). Here, CDKN1A is linked to neoplasm.